The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

The approach -- using a placebo when a "standard-of-care" vaccine already exists -- is contentious within the biomedical ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...

【ジュネーブ=共同】世界保健機関（WHO）の加盟国は20日の総会で、感染症の世界的大流行（パンデミック）への備えやワクチン公平配分の仕組みを定めた新たな国際ルール「パンデミック条約」を採択、同条約が成立した。WHO脱退を表明した米国は総会を欠席した。

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...

Shares of Moderna surged to lead S&P 500 gainers in early afternoon trading Tuesday, hours after the Food and Drug ...

Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults ...

Advisers to the US Food and Drug Administration voted on Tuesday to recommend COVID-19 vaccine booster shots for Americans 65 ...

The U.S. Food and Drug Administration is changing the way it approves COVID-19 vaccines for Americans — a move that will ...

FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...

A Roseland Community Hospital nurse prepares doses of the Pfizer vaccine on Dec. 30, 2021, during a COVID-19 vaccination event at Josephine's Southern Cooking in Chatham, Illinois. (Brian ...